Importin: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 38: | Line 38: | ||
**[[4xzr]] – yIPO NLS-binding domain + HEH1<br /> | **[[4xzr]] – yIPO NLS-binding domain + HEH1<br /> | ||
**[[4pvz]] – yIPO NLS-binding domain + HEH2<br /> | **[[4pvz]] – yIPO NLS-binding domain + HEH2<br /> | ||
**[[4rxh]] – | **[[4rxh]] – NcIPO NLS-binding domain + SV40 large T antigen – ''Neurospora crassa''<br /> | ||
**[[5vqi]] – NcIPO NLS-binding domain + NIT2<br /> | |||
*''IPO-α complex with protein'' | *''IPO-α complex with protein'' | ||
**[[1wa5]] – yIPO NLS-binding domain + GTPase Ran + IPO-α re-exporter<br /> | **[[1wa5]] – yIPO NLS-binding domain + GTPase Ran + IPO-α re-exporter<br /> | ||
**[[5t94]] – yIPO NLS-binding domain + guanine nucleotide exchange factor <br /> | |||
**[[5mfm]] – yIPO NLS-binding domain + YIIIM6AII <br /> | |||
*IPO-α 1 | *IPO-α 1 | ||
| Line 48: | Line 51: | ||
**[[3wpt]] – hIPO NLS-binding domain - human<br /> | **[[3wpt]] – hIPO NLS-binding domain - human<br /> | ||
**[[4b8j]] – rIPO <br /> | **[[4b8j]] – rIPO <br /> | ||
**[[6bvt]] – mIPO NLS-binding domain <br /> | |||
*''IPO-α 1 complex with NLS peptide'' | *''IPO-α 1 complex with NLS peptide'' | ||
| Line 68: | Line 72: | ||
**[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> | **[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> | ||
**[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> | **[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> | ||
**[[6bw0]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | |||
**[[6bw1]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | |||
**[[5w41]] – mIPO NLS-binding domain + Zika virus peptide <br /> | |||
**[[5v5o]], [[5v5p]] – mIPO NLS-binding domain + influenza virus peptide <br /> | |||
**[[5umz]] – mIPO NLS-binding domain + TNRC6A peptide <br /> | |||
**[[5u5p]], [[5u5r]] – mIPO NLS-binding domain + MLH1 peptide <br /> | |||
**[[5gxw]] – mIPO NLS-binding domain + NUMA peptide <br /> | |||
**[[5w4e]], [[5w4f]], [[5w4g]] – hIPO NLS-binding domain + polymerase peptide<br /> | |||
**[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> | |||
**[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | **[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | ||
**[[4b8p]] – rIPO NLS-binding domain + A89<br /> | **[[4b8p]] – rIPO NLS-binding domain + A89<br /> | ||
| Line 116: | Line 129: | ||
*IPO-α 3 | *IPO-α 3 | ||
**[[6bvz]] – hIPO NLS-binding domain <br /> | |||
**[[4uae]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | **[[4uae]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | ||
**[[6bw9]], [[6bwa]], [[6bwb]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | |||
**[[6bvv]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | |||
**[[5xzx]] – hIPO NLS-binding domain + RAN-binding protein peptide<br /> | |||
**[[5tbk]] – hIPO NLS-binding domain + regulator of chromosome condensation <br /> | |||
*IPO-α 6 | *IPO-α 6 | ||
| Line 157: | Line 175: | ||
**[[2z5o]] – hIPO + JKTBP peptide<br /> | **[[2z5o]] – hIPO + JKTBP peptide<br /> | ||
**[[4fdd]], [[4jlq]], [[4oo6]] – hIPO + RNA binding protein peptide<br /> | **[[4fdd]], [[4jlq]], [[4oo6]] – hIPO + RNA binding protein peptide<br /> | ||
**[[5yvg]], [[5yvh]] – hIPO + FUS <br /> | |||
**[[5vyh]], [[5vyi]] – hIPO + FUS peptide<br /> | |||
**[[4fq3]] – hIPO + FUS peptide<br /> | **[[4fq3]] – hIPO + FUS peptide<br /> | ||
**[[5tqc]] – hIPO + RPL4 peptide<br /> | **[[5tqc]] – hIPO + RPL4 peptide<br /> | ||
| Line 171: | Line 191: | ||
**[[5h2v]] – yIPO + ubiquitin-like specific protease<br /> | **[[5h2v]] – yIPO + ubiquitin-like specific protease<br /> | ||
**[[4zj7]] – yIPO + CDC14<br /> | **[[4zj7]] – yIPO + CDC14<br /> | ||
*IPO-4B | |||
**[[5xah]] – hIPO residues 668-1081 <br /> | |||
**[[5xbk]] – hIPO residues 668-1081 + histone H3 peptide <br /> | |||
*IPO-12 (Transportin-3) | *IPO-12 (Transportin-3) | ||